Cao, Davide http://orcid.org/0000-0001-7755-4069
Chandiramani, Rishi http://orcid.org/0000-0001-8659-6850
Capodanno, Davide
Berger, Jeffrey S.
Levin, Matthew A.
Hawn, Mary T.
Angiolillo, Dominick J. http://orcid.org/0000-0001-8451-2131
Mehran, Roxana http://orcid.org/0000-0002-5546-262X
Article History
Accepted: 18 June 2020
First Online: 5 August 2020
Competing interests
: D.Capodanno has received consulting fees or honoraria from Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Daiichi Sankyo and Sanofi. D.J.A. has received grant support, consulting fees and honoraria from Abbott, Amgen, Aralez, Bayer, Biosensors, Boehringer Ingelheim, Bristol Myers Squibb, Chiesi, Daiichi Sankyo, Eli Lilly, Janssen, Merck and Sanofi; consulting fees and honoraria from Haemonetics, the Medicines Company, PhaseBio, PLx Pharma and Pfizer; grant support and fees for review activities from CeloNova; fees for review activities from St Jude Medical; and grant support from CSL Behring, Eisai, Gilead, Idorsia Pharmaceuticals, Matsutani Chemical Industry, Novartis, Osprey Medical, RenalGuard Solutions and the Scott R. MacKenzie Foundation. R.M. has received institutional grants from Abbott, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich; has received personal fees from Abbott, Boston Scientific, Janssen Scientific Affairs, Medscape, Medtelligence (Janssen Scientific Affairs), Roivant Sciences, Sanofi and Siemens Medical Solutions; has received consultant fees paid to the institution from Abbott and Bristol Myers Squibb; has received advisory board funding paid to the institution from Spectranetics/Philips/Volcano Corp; has <1% equity in Claret Medical and Elixir Medical; has received Data and Safety Monitoring Board Membership fees paid to the institution from Watermark Research Partners; has been a consultant (no fee) for Idorsia Pharmaceuticals and Regeneron Pharmaceuticals; and her spouse has received consultant fees from Abiomed and The Medicines Company. All other authors declare no competing interests.